4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Xeris Biopharma Holdings, Inc. (XERS) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Chicago, United States with about 435 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, XERS reported $292M in revenue and $1M in net income.
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.
Interactive charts & full statements → Open the XERS valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $292M | $203M | $164M | $110M | — |
| Gross Profit | $249M | $166M | $135M | $88M | — |
| Operating Income (EBIT) | $25M | ($34M) | ($44M) | ($82M) | — |
| Net Income | $1M | ($55M) | ($62M) | ($95M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $83M | $86M | $74M | $72M | $60M | — |
| Gross Profit | $73M | $75M | $63M | $60M | $51M | — |
| Operating Income (EBIT) | $8M | $17M | $7M | $4M | ($3M) | — |
| Net Income | $2M | $11M | $1M | ($2M) | ($9M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $384M | $323M | $323M | $344M | — |
| Total Liabilities | $370M | $353M | $329M | $299M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive XERS viewer.
About TickerBase · Data methodology & sources